Literature DB >> 5547534

Chloroquine retinopathy. Investigation of discrepancy between dark adaptation and electroretinographic findings in advanced stages.

A E Krill, A M Potts, C E Johanson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5547534     DOI: 10.1016/0002-9394(71)90130-9

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


× No keyword cloud information.
  8 in total

1.  Neurotoxic effects of chloroquine in vitro.

Authors:  A Bruinink; G Zimmermann; F Riesen
Journal:  Arch Toxicol       Date:  1991       Impact factor: 5.153

Review 2.  The cone degenerations.

Authors:  A E Krill; A F Deutman; M Fishman
Journal:  Doc Ophthalmol       Date:  1973-04-16       Impact factor: 2.379

3.  Electrodiagnostic procedures in drug-induced ocular diseases.

Authors:  H E Henkes; A F Deutman
Journal:  Doc Ophthalmol       Date:  1973-02-21       Impact factor: 2.379

Review 4.  Ocular toxicity due to chloroquine and hydroxychloroquine: electrophysiological and visual function correlates.

Authors:  Radouil Tzekov
Journal:  Doc Ophthalmol       Date:  2005-01       Impact factor: 2.379

5.  ERG and other discriminators between advanced hydroxychloroquine retinopathy and retinitis pigmentosa.

Authors:  Archana A Nair; Michael F Marmor
Journal:  Doc Ophthalmol       Date:  2017-04-27       Impact factor: 2.379

6.  ERG findings in patients using hydroxychloroquine.

Authors:  Radouil T Tzekov; Alexandra Serrato; Michael F Marmor
Journal:  Doc Ophthalmol       Date:  2004-01       Impact factor: 2.379

7.  Petaloid-pattern pigmentary retinopathy: a novel case report.

Authors:  Tapas Ranjan Padhi; Subhadra Jalali; Krushna Gopal Panda; Sujoy Mukherjee; Neha Mohan; Pushpalata Agroiya; Taraprasad Das
Journal:  Int Ophthalmol       Date:  2014-02-08       Impact factor: 2.031

8.  The eye and visual nervous system: anatomy, physiology and toxicology.

Authors:  C S McCaa
Journal:  Environ Health Perspect       Date:  1982-04       Impact factor: 9.031

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.